{"id":"W2596227191","doi":"10.1200/jco.2012.30.15_suppl.tps4675","title":"Randomized phase II study of docetaxel with or without ramucirumab (IMC-1121B) or icrucumab (IMC-18F1) in patients with urothelial transitional cell carcinoma (TCC) following progression on first-line platinum-based therapy.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ramucirumab; Docetaxel; Medicine; Paclitaxel; Oncology; Vascular endothelial growth factor; Internal medicine; Cancer research; Cancer; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002036148,0.00197321,0.003809227,0.0004696735,0.0005050592,0.001587369,0.00130562,0.002262375,0.007253782],"category_scores_gemma":[0.001738693,0.001063865,0.001337123,0.0005464603,0.001645335,0.00127971,0.0004628396,0.004071829,0.00180217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001336074,"about_ca_system_score_gemma":0.002234083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001890026,"about_ca_topic_score_gemma":0.004912135,"domain_scores_codex":[0.9993638,0.0003176559,0.00002607533,0.0001167473,0.00003970185,0.0001359908],"domain_scores_gemma":[0.9986948,0.0002544452,0.0001931542,0.0001000991,0.00006952803,0.0006880033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.948171,0.02171133,0.001195823,0.0003431413,0.000526904,0.00008030293,0.00008595936,0.0005890002,0.004481551,0.0001737558,0.001871588,0.02076963],"study_design_scores_gemma":[0.8668969,0.1291757,0.001733731,0.00001672839,0.0002042344,0.00005087152,0.0000231752,0.0003852101,0.000348669,0.0001406648,0.00100931,0.00001479647],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801681,0.003043365,0.0009212801,0.001085175,0.0009611892,0.00785579,0.002015196,0.000220493,0.00372947],"genre_scores_gemma":[0.9801864,0.002327607,0.001863876,0.001588097,0.0004952525,0.005962926,0.002011704,0.0000530813,0.005511124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007253782,"threshold_uncertainty_score":0.02426636,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09876581949273502,"score_gpt":0.439622911102911,"score_spread":0.340857091610176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}